Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Addict Biol. 2013 Apr 16;19(5):849–861. doi: 10.1111/adb.12056

Figure 5.

Figure 5

Effects of pretreatment (−30 min) with the inverse agonist of the type-1 cannabinoid (CB1) receptor SR141716 (0, 0.3, 1, and 3 mg/kg, intraperitoneal) on risk-taking behavior and compulsive eating in male Wistar rats (n=44). (A) Time spent in the open, aversive compartment; (B) food intake. Data represent mean (±SEM). Symbols denote significant difference from Chow/Palatable vehicle treated group *p<0.05, ***p<0.001. § denotes a trend (p=0.07).